Nicole Cossrow, PhD
Senior Principal Scientist
Merck and Co., Inc
2000 Galloping Hill Road
Kenilworth,
NJ
USA
07033
Papers:
2E-5
COST-EFFECTIVENESS OF BEZLOTOXUMAB+STANDARD OF CARE (SOC) VERSUS PLACEBO+SOC FOR THE PREVENTION OF RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN THE UNITED STATES